PharmaTimes Clinical News
Contains all the PharmaTimes latest Clinical News.
Updated: 1 hour 5 min ago
AMS medical research review to consider single regulator
The Academy of Medical Sciences (AMS) has launched a second call for evidence in its review of medical research in the UK, specifically to consider the possibility of bringing all aspects of medical research under a single regulatory umbrella.
Parexel ends fiscal year with Q4 book-to-bill of 2.18
Parexel has started the new financial year in good shape with an impressive net book-to-bill ratio of 2.18 for the fourth quarter of fiscal 2010.
Drug development needs to embrace “clinical/commercial convergence”
The biopharmaceutical development model needs to shift towards a "convergent" path yoking clinical and commercial resources to market access strategy, information and capabilities, argues a new white paper from Quintiles.
Slow enrolment sets back completion date for Vytorin trial
The forecast completion date for a large-scale clinical trial comparing cardiovascular outcomes with Merck & Co’s Vytorin (simvastatin + ezetimibe) and with simvastatin (Zocor) alone has been set back to June 2013 in the face of slow patient enrolment.
Pharmaron consolidates Chinese presence with Bridge acquisition
Pharmaron, a US-based contract research organisation (CRO) with operations both at home and in China, has consolidated its presence in the latter market by acquiring preclinical specialist Bridge Laboratories China for an undisclosed sum.
£5.3 million for EPSRC regenerative medicine centre
The UK government’s Engineering and Physical Sciences Research Council (EPSCRC) is investing £5.3 million over five years in a Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University.
German review finds strong bias in industry-funded trials
The outcomes of industry-funded trials “far more frequently” favour the sponsoring company’s products than when the study funding comes from other sources, a systematic review by German researchers has concluded.
Kendle sees improvement after “particularly challenging” Q1
Cost-cutting and restructuring are bedding in at US-based contract research organisation Kendle, which lifted its net income by 37% in what chief executive officer Candace Kendle described as a “particularly challenging” first quarter.
PPD opens pharmacovigilance centre in Bulgaria
US-based contract research organisation PPD has continued its push into emerging markets for clinical research, opening a pharmacovigilance and medical communications centre in the Bulgarian capital, Sofia.
Pfizer, King’s College form open-innovation partnership for pain
Pfizer and King’s College London in the UK have announced an ‘open innovation’ partnership for pain research that will embed Pfizer scientists at the Wolfson Centre for Age-Related Diseases.
Karo Bio’s eprotirome shows marked LDL reduction in Phase II
A thyroid hormone analogue developed by Swedish company Karo Bio could significantly lower ‘bad’ cholesterol levels in patients already taking statins, and without any significant side-effects, the results of a Phase II trial suggest.
New global biostatistics infrastructure for Kendle
US-based contract research organisation Kendle has put in place a new global biostatistics infrastructure.
Cyprotex acquiring ADMET specialist Apredica for £2.7 million
Cyprotex is acquiring US-based counterpart Apredica for a total of £2.68 million, a move the UK company says will make it the largest international specialist provider of Absorption, Distribution, Metabolism and Elimination/Toxicity CRO services.
Awards give hope to Kendle as Q2 operating income plunges 90%
A nearly 50% sequential increase in new business awards brought some succour to Kendle in another tough quarter, as the CRO saw its operating income plunge by 90.5% against the second quarter of 2009, on a 23.2% drop in net service revenues.
Biovail sells off contract research division to India’s Lambda
Canada's Biovail Corporation has sold off its non-core contract research division to Lambda Therapeutic Research, an international contract research organisation based in Ahmedabad, India.
TKL Research raises European profile with proinnovera stake
US-based clinical research organisation (CRO) TKL Research has raised its profile in the European market by taking an unspecified equity position in proinnovera, a full-service CRO with headquarters in Münster, Germany.
AcPOC design can cut study times by 50%, says Cetero
Using an innovative accelerated proof-of-concept design (AcPOC) for Phase I and II clinical trials can cut study timelines by 50% and costs by more than 10%, says Cetero Research.
Covance expands laboratory capabilities with Greenfield biorepository
Covance has expanded its central laboratory capabilities with a new biorepository facility on its US campus in Greenfield, India.
Cancellations plague PPD in fourth quarter
Contract cancellations and adjustments were worse than expected for PPD in the fourth quarter of 2009, dampening the impact of a financial performance that came in ahead of analysts’ forecasts.
ReNeuron gets final OK for UK stem cell trial
UK-based company ReNeuron Group has crossed the final approval hurdle to taking ReN001, its stem cell therapy for stroke, into patients in its home market.
